Symbol="APRE"
AssetType="Common Stock"
Name="Aprea Therapeutics Inc"
Description="Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and markets cancer therapies that reactivate the mutant p53 tumor suppressor protein. The company is headquartered in Boston, Massachusetts."
CIK="1781983"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="535 BOYLSTON STREET, BOSTON, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="13937800"
EBITDA="-15127635"
PERatio="0.148"
PEGRatio="None"
BookValue="6.28"
DividendPerShare="0"
DividendYield="0"
EPS="25.14"
RevenuePerShareTTM="0.088"
ProfitMargin="0"
OperatingMarginTTM="-60.58"
ReturnOnAssetsTTM="-0.273"
ReturnOnEquityTTM="-0.489"
RevenueTTM="249690"
GrossProfitTTM="0"
DilutedEPSTTM="25.14"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="15"
TrailingPE="0.148"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="1.035"
EVToRevenue="-"
EVToEBITDA="0.129"
Beta="0.166"
num_52WeekHigh="20.75"
num_52WeekLow="0.474"
num_50DayMovingAverage="3.395"
num_200DayMovingAverage="5.53"
SharesOutstanding="3736700"
DividendDate="None"
ExDividendDate="None"
symbol="APRE"
open="3.74"
high="3.77"
low="3.67"
price="3.69"
volume="1757.00"
latest_trading_day="2023-08-31"
previous_close="3.73"
change="-0.04"
change_percent="-1.0724%"
aroon_positive_momentum_days="55"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="55"
Volume_recent_avg="34428"
Change_recent_avg="-0.02"
Delta_recent_avg="0.27"
Variance_recent_avg="0.13"
Change_ratio_recent_avg="-0.5"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="55"
Aroon_momentum_negative="45"
image_negative_thumbnail_id_1="118"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0058.jpeg"
image_negative_thumbnail_id_2="121"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0055.jpeg"
image_neutral_thumbnail_id_1="597"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0002.jpeg"
image_neutral_thumbnail_id_2="573"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0026.jpeg"
image_positive_thumbnail_id_1="954"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0116.jpeg"
image_positive_thumbnail_id_2="661"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0047.jpeg"
image_professor_thumbnail_id_1="1180"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0014.jpeg"
image_professor_thumbnail_id_2="1173"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0007.jpeg"
